does retatrutide work better than tirzepatide vs. Tirzepatide: The New Contender vs. the Current Leader Retatrutide vs Tirzepatide (2026): Differences

However, conflicting evidence highlights context-dependent risks, such as early DR worsening in poorly controlled glycemic states

Based on similar medications, retatrutide probably won't be recommended for: People with a personal or family history of medullary thyroid cancer Those with multiple endocrine neoplasia syndrome type 2 Anyone with a history of pancreatitis Pregnant or breastfeeding women Children and adolescents (under 18) People with severe kidney or liver disease Now, what about people without diabetes who want to lose weight

However, it is not MHRA-approved and cannot be marketed for human consumption or as a licensed medicine

Retatrutide is an investigational compound, and the FDA has not approved it for any indication

Reported side effects include: Other side effects reported include reduced appetite (also a side effect of the drug), tiredness, and skin sensitivity